Dave Thomas | Authors

Thermo Fisher Scientific, Inc.


Analytical Methods to Characterize and Quantify PEG and PEGylated Biopharmaceuticals

Biotherapeutic peptides and proteins are often PEGylated (covalently bonded to polyethylene glycol polymers) to improve bioavailability, reduce immunogenicity, and extend circulating half-life (1). Achieving the desired properties for each application depends on optimizing the number and site of polymers attached, chain length, and the degree of chain branching.